Back to today’s briefing

Story perspectives

Atorvastatin Recall: Heart Risks from Dissolving Defect

11/2/2025

26 6

Summary

Story summary

Ascend Laboratories initiated a recall of atorvastatin that affects hundreds of thousands.
The recall covers batches manufactured by Alkem Laboratories in India that failed to dissolve properly, according to independent testing.
The defect could reduce effectiveness and raise cardiovascular risk.
Patients should not stop atorvastatin without medical advice.
FDA oversight of overseas manufacturers has been limited by COVID-19 travel restrictions.

1 of 1

Story summary

Ascend Laboratories initiated a recall of atorvastatin that affects hundreds of thousands.
The recall covers batches manufactured by Alkem Laboratories in India that failed to dissolve properly, according to independent testing.
The defect could reduce effectiveness and raise cardiovascular risk.
Patients should not stop atorvastatin without medical advice.
FDA oversight of overseas manufacturers has been limited by COVID-19 travel restrictions.